American Oncology Network, Inc., through its subsidiaries, provides oncology services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with complete, accurate and timely pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.

American Oncology Network, Inc.

American Oncology Network provides a network of community oncology practices that ensures local access to cancer care. It focuses on improving quality of care and easing the administrative burden on physicians.

msh id	COM:AONCOLOGY
symbol	AONC
name	American Oncology Network, Inc.
homepage url	https://www.aoncology.com
country	US
sector	Healthcare
industry	Medical - Care Facilities
market	STOCKS
employee count	1.53K
crunchbase url	-
linkedin url	-
founders	-

market cap	14.29M
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	0.13
growth cost of revenue	0.13
growth depreciation and amortization	-0.02
growth ebitda	-0.99
growth ebitda ratio	-0.99
growth eps	-1
growth eps diluted	-1
growth general and administrative expenses	0.12
growth gross profit	-0.13
growth gross profit ratio	-0.22

COM:AONCOLOGY

American Oncology Network

Last Close

4.18

21/11 18:26

Market Cap

14.29M

Beta: -

Volume Today

5.10K

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	1.3B
cost of revenue	1.3B
depreciation and amortization	16.74M
ebitda	261K
ebitda ratio	0
eps	-
eps diluted	-
operating expenses	100.71M
operating income	-49.15M
operating income ratio	-0.04

accounts receivables	6.95M
capital expenditure	-12.28M
cash at beginning of period	26.93M
cash at end of period	28.54M
inventory	44.57M
working capital ttm	130.49M

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-